U.S. Dog and Cat Drug Compounding Market to Surpass US$ 573 Million by 2031 as Personalized Pet Healthcare Gains Momentum
The U.S. dog and cat drug compounding market was valued at US$ 301.5 Mn in 2022 and is projected to grow at a CAGR of 7.3% from 2023 to 2031, reaching more than US$ 573.0 Mn by the end of 2031. The market is witnessing significant growth as pet owners increasingly seek personalized medication solutions to address the unique healthcare needs of companion animals. Drug compounding has emerged as...
0 Commentarii 0 Distribuiri 46 Views 0 previzualizare
Sponsor